IGF-1 levels in turn suppress the activation of endothelial cell proliferation by VEGF, leading to an arrest in the growth of blood vessels that is typical of phase I ROP pathogenesis [31,35]. The gene discussed is VEGFA; the disease is retinopathy of prematurity.